Is Angi, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Angi, Inc. has moved from very attractive to attractive. The company appears to be fairly valued based on its current metrics. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, which suggest that Angi, Inc. is positioned competitively within its industry.
In comparison to peers, Angi, Inc. has a lower P/E ratio than GoodRx Holdings, Inc. at 31.76 and a more favorable EV to EBITDA ratio than eGain Corp. at 23.15. While the company has shown some resilience, the lack of recent return data makes it difficult to assess its performance against the S&P 500. Overall, Angi, Inc. is fairly valued in the current market context.